Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Dev Biol ; 4(3)2016 Aug 03.
Article in English | MEDLINE | ID: mdl-29615588

ABSTRACT

Craniofacial defects (CFD) are a significant healthcare problem worldwide. Understanding both the morphogenetic movements which underpin normal facial development, as well as the molecular factors which regulate these processes, forms the cornerstone of future diagnostic, and ultimately, preventative therapies. The soluble morphogen Sonic hedgehog (Shh), a vertebrate orthologue of Drosophila hedgehog, is a key signalling factor in the regulation of craniofacial skeleton development in vertebrates, operating within numerous tissue types in the craniofacial primordia to spatiotemporally regulate the formation of the face and jaws. This review will provide an overview of normal craniofacial skeleton development, and focus specifically on the known roles of Shh in regulating the development and progression of the first pharyngeal arch, which in turn gives rise to both the upper jaw (maxilla) and lower jaw (mandible).

2.
Proc Natl Acad Sci U S A ; 111(8): 3062-7, 2014 Feb 25.
Article in English | MEDLINE | ID: mdl-24516132

ABSTRACT

Minor class or U12-type splicing is a highly conserved process required to remove a minute fraction of introns from human pre-mRNAs. Defects in this splicing pathway have recently been linked to human disease, including a severe developmental disorder encompassing brain and skeletal abnormalities known as Taybi-Linder syndrome or microcephalic osteodysplastic primordial dwarfism 1, and a hereditary intestinal polyposis condition, Peutz-Jeghers syndrome. Although a key mechanism for regulating gene expression, the impact of impaired U12-type splicing on the transcriptome is unknown. Here, we describe a unique zebrafish mutant, caliban (clbn), with arrested development of the digestive organs caused by an ethylnitrosourea-induced recessive lethal point mutation in the rnpc3 [RNA-binding region (RNP1, RRM) containing 3] gene. rnpc3 encodes the zebrafish ortholog of human RNPC3, also known as the U11/U12 di-snRNP 65-kDa protein, a unique component of the U12-type spliceosome. The biochemical impact of the mutation in clbn is the formation of aberrant U11- and U12-containing small nuclear ribonucleoproteins that impair the efficiency of U12-type splicing. Using RNA sequencing and microarrays, we show that multiple genes involved in various steps of mRNA processing, including transcription, splicing, and nuclear export are disrupted in clbn, either through intron retention or differential gene expression. Thus, clbn provides a useful and specific model of aberrant U12-type splicing in vivo. Analysis of its transcriptome reveals efficient mRNA processing as a critical process for the growth and proliferation of cells during vertebrate development.


Subject(s)
Gene Expression Regulation, Developmental/physiology , Protein Conformation , RNA Splicing/physiology , RNA, Small Nuclear/chemistry , RNA-Binding Proteins/genetics , Spliceosomes/metabolism , Zebrafish Proteins/genetics , Zebrafish/genetics , Animals , Base Sequence , Gene Expression Profiling , Gene Expression Regulation, Developmental/genetics , Intestines/abnormalities , Liver/abnormalities , Microarray Analysis , Molecular Sequence Data , Pancreas/abnormalities , Point Mutation/genetics , RNA Splicing/genetics , RNA-Binding Proteins/metabolism , Real-Time Polymerase Chain Reaction , Sequence Analysis, RNA , Spliceosomes/genetics , Zebrafish/growth & development , Zebrafish Proteins/metabolism
3.
Cancer Cell ; 24(2): 257-71, 2013 Aug 12.
Article in English | MEDLINE | ID: mdl-23948300

ABSTRACT

Among the cytokines linked to inflammation-associated cancer, interleukin (IL)-6 drives many of the cancer "hallmarks" through downstream activation of the gp130/STAT3 signaling pathway. However, we show that the related cytokine IL-11 has a stronger correlation with elevated STAT3 activation in human gastrointestinal cancers. Using genetic mouse models, we reveal that IL-11 has a more prominent role compared to IL-6 during the progression of sporadic and inflammation-associated colon and gastric cancers. Accordingly, in these models and in human tumor cell line xenograft models, pharmacologic inhibition of IL-11 signaling alleviated STAT3 activation, suppressed tumor cell proliferation, and reduced the invasive capacity and growth of tumors. Our results identify IL-11 signaling as a potential therapeutic target for the treatment of gastrointestinal cancers.


Subject(s)
Cell Transformation, Neoplastic/immunology , Gastrointestinal Neoplasms/immunology , Interleukin-11/metabolism , Interleukin-6/metabolism , Animals , Gastric Mucosa/immunology , Gastric Mucosa/metabolism , Gastrointestinal Neoplasms/genetics , Gastrointestinal Neoplasms/therapy , Humans , Interleukin-11/genetics , Interleukin-11/immunology , Interleukin-6/genetics , Interleukin-6/immunology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Nude , Molecular Targeted Therapy , Xenograft Model Antitumor Assays
4.
PLoS Genet ; 9(2): e1003279, 2013.
Article in English | MEDLINE | ID: mdl-23408911

ABSTRACT

Ribosome biogenesis underpins cell growth and division. Disruptions in ribosome biogenesis and translation initiation are deleterious to development and underlie a spectrum of diseases known collectively as ribosomopathies. Here, we describe a novel zebrafish mutant, titania (tti(s450)), which harbours a recessive lethal mutation in pwp2h, a gene encoding a protein component of the small subunit processome. The biochemical impacts of this lesion are decreased production of mature 18S rRNA molecules, activation of Tp53, and impaired ribosome biogenesis. In tti(s450), the growth of the endodermal organs, eyes, brain, and craniofacial structures is severely arrested and autophagy is up-regulated, allowing intestinal epithelial cells to evade cell death. Inhibiting autophagy in tti(s450) larvae markedly reduces their lifespan. Somewhat surprisingly, autophagy induction in tti(s450) larvae is independent of the state of the Tor pathway and proceeds unabated in Tp53-mutant larvae. These data demonstrate that autophagy is a survival mechanism invoked in response to ribosomal stress. This response may be of relevance to therapeutic strategies aimed at killing cancer cells by targeting ribosome biogenesis. In certain contexts, these treatments may promote autophagy and contribute to cancer cells evading cell death.


Subject(s)
Autophagy/genetics , Cell Cycle Proteins , Ribosomes , TOR Serine-Threonine Kinases , Tumor Suppressor Protein p53 , Zebrafish Proteins , Animals , Cell Cycle Proteins/genetics , Cell Cycle Proteins/metabolism , Cell Survival , Genes, Lethal/genetics , Mutation , Protein Biosynthesis/genetics , RNA, Ribosomal, 18S/genetics , RNA, Ribosomal, 18S/metabolism , Ribosomes/genetics , Ribosomes/metabolism , TOR Serine-Threonine Kinases/genetics , TOR Serine-Threonine Kinases/metabolism , Tumor Suppressor Protein p53/genetics , Zebrafish/genetics , Zebrafish/metabolism , Zebrafish Proteins/genetics , Zebrafish Proteins/metabolism
5.
Dev Biol ; 349(2): 512-22, 2011 Jan 15.
Article in English | MEDLINE | ID: mdl-21081122

ABSTRACT

The Grainy head-like 3 (Grhl3) gene encodes a transcription factor that plays essential roles in epidermal morphogenesis during embryonic development, with deficient mice exhibiting failed skin barrier formation, defective wound repair, and loss of eyelid fusion. Despite sharing significant sequence homology, overlapping expression patterns, and an identical core consensus DNA binding site, the other members of the Grhl family (Grhl1 and -2) fail to compensate for the loss of Grhl3 in these processes. Here, we have employed diverse genetic models, coupled with biochemical studies, to define the inter-relationships of the Grhl factors in epidermal development. We show that Grhl1 and Grhl3 have evolved complete functional independence, as evidenced by a lack of genetic interactions in embryos carrying combinations of targeted alleles of these genes. In contrast, compound heterozygous Grhl2/Grhl3 embryos displayed failed wound repair, and loss of a single Grhl2 allele in Grhl3-null embryos results in fully penetrant eyes open at birth. Expression of Grhl2 from the Grhl3 locus in homozygous knock-in mice corrects the wound repair defect, but these embryos still display a complete failure of skin barrier formation. This functional dissociation is due to unexpected differences in target gene specificity, as both GRHL2 and GRHL3 bind to and regulate expression of the wound repair gene Rho GEF 19, but regulation of the barrier forming gene, Transglutaminase 1 (TGase1), is unique to GRHL3. Our findings define the mechanisms underpinning the unique and cooperative roles of the Grhl genes in epidermal development.


Subject(s)
DNA-Binding Proteins/metabolism , Epidermis/embryology , Morphogenesis/physiology , Phenotype , Repressor Proteins/metabolism , Transcription Factors/metabolism , Animals , DNA Primers/genetics , DNA-Binding Proteins/genetics , Electrophoretic Mobility Shift Assay , Epidermis/ultrastructure , Gene Knock-In Techniques , Immunohistochemistry , In Situ Hybridization , Mice , Microscopy, Electron, Scanning , Repressor Proteins/genetics , Reverse Transcriptase Polymerase Chain Reaction , Transcription Factors/genetics , Transglutaminases/metabolism , Wound Healing/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...